Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase RNA specific B1 | 0.588 | 0.654 | 0.80 |
|
disease | 0.320 | None | 0.333 | 3 | 0 | 2004 | 2014 | ||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
disease | 0.370 | None | 0.400 | 5 | 0 | 1999 | 2004 | |||||||||
|
glutamate ionotropic receptor AMPA type subunit 1 | 0.570 | 0.577 | 1.00 |
|
disease | 0.320 | None | 0.500 | 4 | 0 | 2007 | 2012 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.330 | None | 0.500 | 4 | 0 | 2012 | 2013 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.570 | None | 0.500 | 4 | 0 | 2000 | 2019 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2003 | 2011 | ||||||||
|
arginine vasopressin receptor 1B | 0.705 | 0.385 | 3.7E-04 |
|
disease | 0.330 | None | 0.500 | 2 | 0 | 2012 | 2013 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
disease | 0.330 | None | 0.500 | 2 | 0 | 2011 | 2016 | ||||||||
|
long intergenic non-protein coding RNA 2694 | 0.780 | 0.308 | 1.7E-02 |
|
disease | 0.420 | None | 0.500 | 2 | 3 | 2008 | 2019 | ||||||||
|
proline dehydrogenase 1 | 0.612 | 0.692 | 5.4E-12 |
|
disease | 0.300 | None | 0.500 | 2 | 0 | 2006 | 2006 | ||||||||
|
solute carrier family 17 member 7 | 0.636 | 0.308 | 1.00 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2009 | 2010 | ||||||||
|
charged multivesicular body protein 1B | 0.736 | 0.462 | 0.73 |
|
disease | 0.300 | None | 0.500 | 2 | 0 | 2005 | 2007 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2003 | 2004 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.340 | None | 0.500 | 2 | 0 | 1997 | 2016 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2010 | 2013 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.530 | 0.692 | 0.98 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2011 | 2012 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
disease | 0.330 | None | 0.500 | 2 | 0 | 2008 | 2017 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2005 | 2010 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2001 | 2018 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.340 | None | 0.500 | 2 | 0 | 2010 | 2018 | ||||||||
|
synaptogyrin 1 | 0.736 | 0.346 | 0.45 |
|
disease | 0.330 | None | 0.500 | 2 | 0 | 2005 | 2009 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 3 | 0.544 | 0.615 | 1.00 |
|
disease | 0.520 | None | 0.500 | 2 | 0 | 1998 | 2001 | ||||||||
|
phospholipase A2 group IIA | 0.488 | 0.808 | 9.7E-02 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2003 | 2011 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 1 | 0.561 | 0.692 | 0.98 |
|
disease | 0.340 | None | 0.500 | 2 | 0 | 2003 | 2012 | ||||||||
|
modulator of VRAC current 1 | 0.585 | 0.769 | 3.2E-08 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2005 | 2007 |